RE:Have a readOK... well show the market a copy of the study - we don't need to see how you have created the product - just show us a peer reviewed paper that give some proof it works. Shareholders would like nothing more than this to true - how about that for the next NR
In other words, these hops-based CBD strains will allegedly do a better job at treating your ailments than cannabis-based CBD ever has.
This is partly because ImmunAG is a time-release tablet that does not dissolve in the stomach, but rather, dissolves in the lower intestine. This creates greater bioactivity, says Hussey.
“The body has a process that it goes through [when you ingest a product] and that process damages how effective the product’s bioavailability and bioactivity are. If the product isn’t processed in the right part of the body – which, for us at this point is the small intestine – and if it doesn’t make it through the tract before it releases the CBD, the reality is that you’re not getting the CBD that you put in your body,” says Hussey.
Read more at https://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=27151602#GW70Z6VREq5QeLsr.99